TipRanks
Tandem Diabetes Care (MX:TNDM)
:TNDM
Mexico Market
TNDM
Tandem Diabetes Care
RESEARCH TOOLSreports

Tandem Diabetes Care (TNDM) Stock News & Sentiment

0 Followers
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
Premium
Ratings
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
1M ago
TNDM
Tandem Diabetes Care Earnings Call Highlights Growth
Premium
Company Announcements
Tandem Diabetes Care Earnings Call Highlights Growth
1M ago
TNDM
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
Premium
Ratings
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
1M ago
TNDM
TNDM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TNDM Earnings this Week: How Will it Perform?
1M ago
TNDM
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
Premium
Ratings
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
3M ago
TNDM
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
Premium
Company Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
4M ago
8K
TNDM
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
Premium
Company Announcements
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
4M ago
TNDM
More MX:TNDM News >

TNDM News on the Web

After a sell-off, this medical device stock looks like a gift for patient investors
CNBC
Neutral
Tandem Diabetes Care Earnings Call Highlights Growth
TipRanks News
Bullish
Tandem Diabetes Care (TNDM) Gets a Hold from Goldman Sachs
TipRanks News
Neutral
Tandem Diabetes price target lowered to $20 from $24 at Mizuho
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)
TipRanks News
Bullish
Insulet price target lowered to $245 from $280 at RBC Capital
TipRanks News
Neutral
Citi Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)
TipRanks News
Neutral
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MX:TNDM
Sector Average
Media Buzz
This Week2 articles
Weekly Average6.75 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:TNDM’s Media Buzz Sentiment?
2 articles about MX:TNDM were published this week. In an average week, 6.75 articles are published.
    What is MX:TNDM’s weekly average amount of articles?
    In an average week, 6.75 articles about MX:TNDM are published.
      What is MX:TNDM’s News Sentiment?
      50% of articles about MX:TNDM were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SLDBSolid Biosciences
        CRLCharles River Labs
        ASNDAscendis Pharma
        CRBPCorbus Pharmaceuticals
        RVMDRevolution Medicines
        Showing the stocks with the most bullish news sentiment over the past week